Page last updated: 2024-09-05

erlotinib hydrochloride and Esophageal Reflux

erlotinib hydrochloride has been researched along with Esophageal Reflux in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Basappa, N; Butts, CA; Chambers, CR; Chu, MP; Chu, Q; Fenton, D; Ghosh, S; Joy, AA; Sangha, R; Sawyer, MB; Smylie, M	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Esophageal Reflux

Article	Year
Gastric Acid suppression is associated with decreased erlotinib efficacy in non-small-cell lung cancer. Clinical lung cancer, 2015, Volume: 16, Issue:1 Topics: Carcinoma, Non-Small-Cell Lung; Drug Interactions; Erlotinib Hydrochloride; Female; Gastric Acid; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lung Neoplasms; Male; Middle Aged; Omeprazole; Population Groups; Protein Kinase Inhibitors; Quinazolines; Retrospective Studies; Survival Analysis; Treatment Outcome	2015

Article

Year

Gastric Acid suppression is associated with decreased erlotinib efficacy in non-small-cell lung cancer.

Clinical lung cancer, 2015, Volume: 16, Issue:1

Topics: Carcinoma, Non-Small-Cell Lung; Drug Interactions; Erlotinib Hydrochloride; Female; Gastric Acid; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lung Neoplasms; Male; Middle Aged; Omeprazole; Population Groups; Protein Kinase Inhibitors; Quinazolines; Retrospective Studies; Survival Analysis; Treatment Outcome

2015